Clay Thorp, Director, 10% Owner at Clearside Biomedical, Inc. (CLSD), sold 112,940 shares at $7.43 ($843K) on 2017-04-17, disclosed to the SEC on 2017-04-19.
Open-market sale of $843k CLSD by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.43 | 22,000 | $163K | 19.4% |
| 2 | $7.48 | 44,455 | $333K | 39.4% |
| 3 | $7.48 | 44,455 | $333K | 39.4% |
| 4 | $7.37 | 2,030 | $15K | 1.8% |
| Total | $7.47 avg | 112,940 | $843K | 100% |
| Filing → |
| CLSD | BUY | 2022-12-21 | $14K | — | Filing → |
| VIGL | BUY | 2022-05-17 | $165K | — | Filing → |
| VIGL | BUY | 2022-03-28 | $22K | — | Filing → |